This site uses cookies and similar technologies.

If you do not change your browser settings, then you agree to their use

I understand
about-us1

About us

A dynamic, modern business providing quality medicines in the most cost effective and efficient manner

Read more >

Partnerships

Proud to partner with the NHS and exceptional businesses in the UK and around the world

Read more >
products2

Products

Explore our expanding portfolio of products across a broad range of therapeutic areas

Read more >

Headline brands

A collection of ambassador products that demonstrate our ethos – providing quality medicines tailored to patients’ and providers’ needs

Read more >

 

Aspire Pharma acquires Morningside Pharmaceuticals and Morningside Healthcare and its subsidiaries, including Morningside Healthcare (India) creating the UK’s premier Specialty Pharma company. To read more please click here

 

Doxepin Capsules

Morningside is pleased to announce the launch of Doxepin 10mg, 25mg and 50mg Capsules1-3 which are available to order now from pharmaceutical wholesalers

 

For further sales information please contact customer services on 01509 217705 or email This email address is being protected from spambots. You need JavaScript enabled to view it.
 
For medical enquiries please contact medical information on +44 (0) 116 478 0322.

Click here for Doxepin 10mg Capsules SmPC
Click here for Doxepin 25mg Capsules SmPC
Click here for Doxepin 50mg Capsules SmPC

1. Morningside Healthcare Ltd. Doxepin 10mg Capsules. Summary of Product Characteristics. October 2021. Available at: https://www.medicines.org.uk/emc/product/13350/smpc (accessed May 2022); 2. Morningside Healthcare Ltd. Doxepin 25mg Capsules. Summary of Product Characteristics. October 2021. Available at: https://www.medicines.org.uk/emc/product/13351/smpc (accessed May 2022); 3. Morningside Healthcare Ltd. Doxepin 50mg Capsules. Summary of Product Characteristics. October 2021. Available at: https://www.medicines.org.uk/emc/product/13352/smpc (accessed May 2022).

Please refer to full SmPC text before prescribing. Adverse events should be reported. Reporting forms and information can be found at www.mhra.gov.uk/yellowcard or search for MHRA Yellow Card in the Google Play or Apple App Store. Adverse events should also be reported to Morningside Healthcare Ltd.’s Medical Information Department on Tel: 0116 478 0322.

Please refer to full SmPC text before prescribing. Adverse events should be reported. Reporting forms and information can be found at www.mhra.gov.uk/yellowcard or search for MHRA Yellow Card in the Google Play or Apple App Store. Adverse events should also be reported to Morningside Healthcare Ltd.’s Medical Information Department on Tel: 0116 478 0322.

MHL_1_21.06.2023 | Date of preparation: June 2023